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Abstract: Intensive care management of cardiovascular disease and dysfunction, a major and growing 
issue, would benefit from improved synthesis of continuously monitored, information rich catheter 
waveforms into clear, relevant cardiac metrics. Volume measurements are rarely taken in intensive care, 
but advances have been made in approximating cardiac stroke volume using pressure measurements. This 
paper proposes a method for the minimally invasive, real-time, beat-to-beat estimation of end-systolic 
volume, with the goal of providing further insight into cardiac volume behavior and access to important 
metrics such as cardiac preload. This method relies on a modified end-systolic pressure-volume relation, 
aortic pressure and heart rate data and a brief echocardiography calibration. The method was validated 
across 11 pigs and 2 protocols, encompassing the progression of sepsis and a variety clinical procedures 
employed in the management of sepsis. The method demonstrated consistently strong correlation 
coefficients, with a mean of R = 0.82, and low estimation error, with a mean absolute percentage error of 
13.3%. This method thus allows effective estimation of end-systolic volume, providing a more complete 
picture of cardiac behavior in an intensive care environment in which volume measurements are rarely 
taken. As such, the method has the potential to benefit clinical decision making and management of 
cardiovascular disease and dysfunction. 




Cardiovascular disease and dysfunction (CVD) is a major and 
growing health issue, responsible for significant social and 
economic costs globally. In 2013, CVD was responsible for 
31% of global deaths, and in 2010, global expenditure on CVD 
($863 billion USD) was equivalent to 1.39% of gross world 
product for that year (Roger et al., 2012). These figures are set 
to rise, driven by an aging population. As such, there is a clear 
need to reduce incidences of inadequate or incorrect diagnosis 
of cardiac disturbances in the Intensive Care Unit (ICU), 
which contribute to increased length of stay, cost, and 
mortality (Angus et al., 2001, Pineda et al., 2001). 
Management of CVD in the ICU typically occurs in an 
information rich environment, provided by a variety of 
instruments including catheters placed near the heart that 
directly measure arterial and venous pressure waveforms. 
However, despite the abundance of information provided by 
such instruments, their use is not necessarily associated with 
improved clinical outcomes (Frazier and Skinner, 2008, 
Chatterjee, 2009). Control and management of CVD in the 
ICU requires better real-time synthesis of clear biological 
markers to make this information rich and complex system 
easier to interpret. 
Examples of such biological markers are preload and afterload. 
Afterload serves as an indicator of the pressure downstream 
from the left ventricle, and is sensitive to alterations in valve 
function and arterial tone (Hall, 2010).  Afterload is 
approximated in the ICU via the typically measured, resulting 
aortic pressure (Pao) (Kelly et al., 1990). Preload, representing 
the loading conditions upstream from the heart, is sensitive to 
venous blood pressure and return, which are in turn sensitive 
to circulatory volume and venous tone (Hall, 2010). Preload is 
typically represented by End-Diastolic Volume (Ved) (Michard 
et al., 2003), but this value  is not typically measured in the 
ICU as the required instrumentation is too invasive. As a 
result, clinical approximation is difficult. In fact, volume and 
flow measurements, in general, are rarely taken in the ICU 
(Kamoi et al., 2014), resulting in a relative abundance of 
pressure measurements, but an incomplete picture of cardiac 
behaviour. 
Recent work has provided a means of approximating the beat-
to-beat cardiac stroke volume (SV) under typical ICU 
instrumentation (Kamoi et al., 2014). SV provides a beat-to-
beat indicator of the how much heart volume is changing, but 
must be combined with a beat-to-beat absolute maximum or 
minimum value to provide a more complete picture of cardiac 
volume behaviour, and thus allow approximation of cardiac 
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aortic pressure and heart rate data and a brief echocardiography calibration. The method was validated 
across 11 pigs and 2 protocols, encompassing the progression of sepsis and a variety clinical procedures 
employed in the management of sepsis. The method demonstrated consistently strong correlation 
coefficients, with a mean of R = 0.82, and low estimation error, with a mean absolute percentage error of 
13.3%. This method thus allows effective estimation of end-systolic volume, providing a more complete 
picture of cardiac behavior in an intensive care environment in which volume measurements are rarely 
taken. As such, the method has the potential to benefit clinical decision making and management of 
cardiovascular disease and dysfunction. 




Cardiovascular disease and dysfunction (CVD) is a major and 
growing health issue, responsible for significant social and 
economic costs globally. In 2013, CVD was responsible for 
31% of global deaths, and in 2010, global expenditure on CVD 
($863 billion USD) was equivalent to 1.39% of gross world 
product for that year (Roger et al., 2012). These figures are set 
to rise, driven by an aging population. As such, there is a clear 
need to reduce incidences of inadequate or incorrect diagnosis 
of cardiac disturbances in the Intensive Care Unit (ICU), 
which contribute to increased length of stay, cost, and 
mortality (Angus et al., 2001, Pineda et al., 2001). 
Management of CVD in the ICU typically occurs in an 
information rich environment, provided by a variety of 
instruments including catheters placed near the heart that 
directly measure arterial and venous pressure waveforms. 
However, despite the abundance of information provided by 
such instruments, their use is not necessarily associated with 
improved clinical outcomes (Frazier and Skinner, 2008, 
Chatterjee, 2009). Control and management of CVD in the 
ICU requires better real-time synthesis of clear biological 
markers to make this information rich and complex system 
easier to interpret. 
Examples of such biological markers are preload and afterload. 
Afterload serves as an indicator of the pressure downstream 
from the left ventricle, and is sensitive to alterations in valve 
function and arterial tone (Hall, 2010).  Afterload is 
approximated in the ICU via the typically measured, resulting 
aortic pressure (Pao) (Kelly et al., 1990). Preload, representing 
the loading conditions upstream from the heart, is sensitive to 
venous blood pressure and return, which are in turn sensitive 
to circulatory volume and venous tone (Hall, 2010). Preload is 
typically represented by End-Diastolic Volume (Ved) (Michard 
et al., 2003), but this value  is not typically measured in the 
ICU as the required instrumentation is too invasive. As a 
result, clinical approximation is difficult. In fact, volume and 
flow measurements, in general, are rarely taken in the ICU 
(Kamoi et al., 2014), resulting in a relative abundance of 
pressure measurements, but an incomplete picture of cardiac 
behaviour. 
Recent work has provided a means of approximating the beat-
to-beat cardiac stroke volume (SV) under typical ICU 
instrumentation (Kamoi et al., 2014). SV provides a beat-to-
beat indicator of the how much heart volume is changing, but 
must be combined with a beat-to-beat absolute maximum or 
minimum value to provide a more complete picture of cardiac 
volume behaviour, and thus allow approximation of cardiac 
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preload. There is thus a need to relate either End-Systolic (Ves) 
or End-Diastolic (Ved) Volume to existing pressure 
measurements. An existing and frequently used example of 
such relationship is the End-Systolic Pressure-Volume 
Relation (ESPVR) (Senzaki et al., 1996, Grossman et al., 1977, 
Crottogini et al., 1988). However, this relation relies upon 
several subject specific parameters that are measurable in an 
experimental environment, but too invasive to measure 
clinically. 
The focus of this paper is to investigate the viability of using a 
modified ESPVR to provide a beat-by beat approximation of 
Ves, allowing, in concert with SV, approximation of Ved 
(preload) and a more complete picture of cardiac volume 
behaviour. This modified ESPVR relies on continuous heart 
rate and aortic pressure data, and initial parameters being fixed 
during a brief (10 heartbeat) echocardiography calibration 
during which non-invasive volume measurements are 
available (Lang et al., 2015). These short echocardiography 
readings are becoming increasingly available in a clinical 
environment (Vieillard-Baron et al., 2008). This method, if 
able to effectively track Ves through changing patient 
behaviour and condition over a sustained period of monitoring, 
has the potential to aid in the provision of a more complete 
picture of cardiac behaviour under normal ICU 
instrumentation. This outcome provides additional 
information and metrics to aid real-time clinical management 
and decision making, potentially improving clinical outcomes. 
2. METHODS 
2.1  Experimental Protocols 
Eleven male, pure Piétrain pigs weighing 18.5 to 29 kg were 
subject to two distinct protocols approved by the Ethics 
Commission for the Use of Animals at the University of Liège, 
Belgium. The pigs were sedated, anaesthetised and 
mechanically ventilated (GE Engstrom CareStation) with a 
baseline positive end-expiratory pressure (PEEP) of 5 cmH2O. 
The heart was accessed via a median sternotomy, and an 
admittance pressure-volume catheter (Transonic, NY, USA) 
with a sampling rate of 250 Hz inserted into the left ventricle. 
Proximal aortic pressure was continually sampled using a 
pressure catheter (Transonic, NY, USA) with a sampling rate 
of 250 Hz.  
To ensure a diverse range of cardiac states was exhibited, 
several procedures were performed:  
 Protocol 1: A single infusion of endotoxin 
(lipopolysaccharide from E. Coli, 0.5 mg/kg injected 
over 30 minutes) to induce septic shock, which drives 
a change in afterload conditions and is associated 
with a large variety of effects including an 
inflammatory response and capillary leakage that 
may lead to hypovolemia, global tissue hypoxia  and 
cardiac failure (Nguyen et al., 2006).  
 Protocol 2: An infusion of dobutamine over a period 
of 30 minutes. Dobutamine directly increases 
contractility in order to improve cardiac output, and 
is a key component in hemodynamic resuscitation in 
patients with severe sepsis (Dellinger et al., 2008). 
 Protocols 1 & 2: Several Positive End-Expiratory 
Pressure (PEEP) driven recruitment manoeuvres 
(RMs), both pre- and post- endotoxin/dobutamine 
infusion, which drive a change in preload conditions 
and are typically associated with a decrease in mean 
blood pressure and cardiac output (Jardin et al., 
1981). 
 Protocols 1 & 2: One to four infusions of 500 mL 
saline solution over 30 minute periods, pre- and post- 
endotoxin/dobutamine infusion, simulating fluid 
resuscitation therapy, another key component of 
hemodynamic resuscitation in patients with severe 
sepsis, which itself results in a change in circulatory 
volume (Vincent and Gerlach, 2004). 
2.2  ESPVR 
The ESPVR is typically expressed (Sagawa, 1981): 
𝑃𝑃𝑒𝑒𝑒𝑒 = 𝐸𝐸𝑒𝑒𝑒𝑒×(𝑉𝑉𝑒𝑒𝑒𝑒 − 𝑉𝑉0) (1) 
where Pes is the end-systolic pressure, Ves the end-systolic 
volume, Ees the end-systolic elastance and V0 the ventricular 
volume at zero pressure. This relationship represents the 
ventricular volume corresponding to a given ventricular 
pressure when the heart is fully contracted (end-systole).   
The exact nature of Ees is somewhat controversial. It has been 
argued that it is constant for a given contractility (Suga et al., 
1973), though there is evidence that suggests it varies as a 
result of loading conditions (Burkhoff et al., 1993, Baan and 
Van Der Velde, 1988). As the intent is to be able to track Ves 
through changes in contractility, a fixed value for Ees is clearly 
not appropriate for ICU monitoring, or for an experimental 
data set encompassing sepsis and dobutamine where 
contractility is directly varied dramatically due to condition 
and drug therapy.  
2.3  Proposed Method 
While a number of the components of ESPVR are not 
measured under typical ICU instrumentation, it is possible to 
replace these values with physiologically similar and more 
easily obtained measurements. ESPVR is thus re-factored: 
𝑃𝑃𝐷𝐷𝐷𝐷 = 𝐸𝐸𝑒𝑒𝑒𝑒×(𝑉𝑉𝑒𝑒𝑒𝑒 − 𝑉𝑉𝑑𝑑) (2) 
Where: 
 Pes is replaced by PDN (Dicrotic notch pressure in the 
aorta), as the aorta sits directly downstream from the 
left ventricle, thus aortic and left-ventricular pressure 
are very similar (with a slight difference due to aortic 
valve resistance) during systole. As real-time aortic 
pressure is typically available in the ICU, PDN 
provides a readily available surrogate for Pes. 
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 V0 is replaced by Vd (Ventricular Dead Space 
Volume), as the two are often used interchangeably, 
and have similar physiological roles and values 
(Sagawa, 1981, Stevenson et al., 2012b, Stevenson et 
al., 2012a). Vd can be more easily estimated than V0, 
via a relationship with baseline Ves (Davidson et al., 
2017): 
𝑉𝑉𝑑𝑑 = 0.48×𝑉𝑉𝑒𝑒𝑒𝑒(𝐵𝐵𝐵𝐵𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠) (3) 
Finally, the fact that Ees changes as patient contractility, and 
potentially loading conditions, vary, needs to be accounted for. 
The decision was made to approximate Ees using a power 
relationship with Heart Rate (HR) for several reasons. First, 
changes in HR and Ees are staple cardiovascular system 
responses to changing conditions (Hall, 2010). As continuous 
monitoring of HR in the ICU is commonplace, it provides a 
partial, if incomplete, picture of cardiovascular system 
response, which is typically sympathetic with changes in Ees. 
Second, a power relationship was selected as it suits a 
sympathetic relationship and is sufficiently simple, provided 
the exponent is fixed a priori, that it can be uniquely 
determined during a 10 heartbeat echocardiography 
calibration. Thus, this relationship captures, in a simplified 
manner, physiological elements and suits the need for method 






+ 𝑉𝑉𝑑𝑑 (4) 
with n to be determined and then fixed a priori. Thus, in the 
model implementation, PDN and HR are inputs that are 
measured every heartbeat, n is fixed a priori, and Vd and Ec are 
fixed for the duration of monitoring during the calibration 
phase, where Ves is being measured. The results section 
presents an assessment of the increase in errors associated with 
the transition from a subject specific to an a priori value of n. 
2.4  Analysis 
Linear least squares, performed using MATLAB (R2014a, 64-
bit) and the ‘lsqlin’ function, was used to determine a subject 
specific exponent n that minimised method errors for each of 
the 11 pigs (Ec can be analytically determined for a given n 
during the echocardiography calibration, and is thus a 
dependent parameter). The overall process for determining the 
approximate beat-to-beat Ves curve using the a priori exponent 
was as follows: 
1. Determine Vd (Eq. 3) and EC (Eq. 4) from a 10 
heartbeat ‘calibration’ period where Ves is measured, 
simulating an echocardiography reading. 
2. Determine Ves for each subsequent heartbeat based on 
the fixed values (Vd and EC) and heartbeat specific 
measured values (HR and PDN). 
Overall evaluation of the effectiveness of the method was 
accomplished in several ways: 
 Using Pearson’s correlation coefficients (R), which 
allow evaluation of the method’s capability to capture 
trends in Ves over the course of the two protocols 
investigated, and thus provide benefits in monitoring 
patient condition. 
 Using the absolute percentage error for each pig, 
which allows an evaluation of the ability of the 
method to accurately approximate the exact value of 
Ves, and thus the suitability of this method for use as 
a component of a larger model. 
 Via direct visual evaluation of the trendlines, which 
is only possible due to the relatively small number of 
subjects (11), but does provide a means of evaluating 
the temporal and procedure based variations in 
method effectiveness.  
A comparison across these metrics was made between Ves 
curves estimated using subject specific n, and Ves curves 
estimated by the a priori fixed n, which provides an indication 
of how much method accuracy is lost in the reliance on an a 
priori exponent. Overall, this analysis was conducted over 11 
individuals across two protocols, encompassing a total of 
166,659 heartbeats of data. 
3. RESULTS 
Table 1 provides an overview of the subject specific 
exponents, n, provided by linear least squares, along with the 
associated correlation coefficients and error values for 
tracking Ves. As can be seen, the correlation coefficients are 
high, with a mean of 0.83. Further, overall error values are 
relatively low, except for Pig D4 and the 75th percentile error 
for Pig D5. It is also interesting to note the generally higher 
error values for protocol 2 (dobutamine, Pig D-) compared to 
protocol 1 (sepsis, Pig S-). It was decided, for simplicity, to set 
the a priori value of n to 3 based on these results. 
Table 1. Tracking Ves with Subject Specific n: Correlation 








Pig S1 3.06 0.93 1.7 (0.9 - 3) 
Pig S2 4.02 0.94 2.9 (1.5 - 4.8) 
Pig S3 2.06 0.87 4.6 (2.2 - 7.2) 
Pig S4 2.72 0.8 4.7 (2.1 - 8.2) 
Pig S5 4.27 0.81 2.3 (0.9 - 7.7) 
Pig D1 1.8 0.87 12.2 (3 - 26.7) 
Pig D2 1.93 0.88 11.5 (5.8 - 22) 
Pig D3 3.24 0.85 19.3 (9.9 - 34.4) 
Pig D4 4.16 0.67 31.8 (15.9 - 49.1) 
Pig D5 3.55 0.91 15.7 (5.6 - 82.6) 
Pig D6 0.98 0.6 6.6 (2.8 - 13.2) 
Mean 2.89 0.83 10.3 (4.6 - 23.5) 
 
Table 2 provides an overview of the correlation coefficients 
and error values associated with tracking Ves using an a priori 
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phase, where Ves is being measured. The results section 
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2.4  Analysis 
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bit) and the ‘lsqlin’ function, was used to determine a subject 
specific exponent n that minimised method errors for each of 
the 11 pigs (Ec can be analytically determined for a given n 
during the echocardiography calibration, and is thus a 
dependent parameter). The overall process for determining the 
approximate beat-to-beat Ves curve using the a priori exponent 
was as follows: 
1. Determine Vd (Eq. 3) and EC (Eq. 4) from a 10 
heartbeat ‘calibration’ period where Ves is measured, 
simulating an echocardiography reading. 
2. Determine Ves for each subsequent heartbeat based on 
the fixed values (Vd and EC) and heartbeat specific 
measured values (HR and PDN). 
Overall evaluation of the effectiveness of the method was 
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 Using Pearson’s correlation coefficients (R), which 
allow evaluation of the method’s capability to capture 
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investigated, and thus provide benefits in monitoring 
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 Using the absolute percentage error for each pig, 
which allows an evaluation of the ability of the 
method to accurately approximate the exact value of 
Ves, and thus the suitability of this method for use as 
a component of a larger model. 
 Via direct visual evaluation of the trendlines, which 
is only possible due to the relatively small number of 
subjects (11), but does provide a means of evaluating 
the temporal and procedure based variations in 
method effectiveness.  
A comparison across these metrics was made between Ves 
curves estimated using subject specific n, and Ves curves 
estimated by the a priori fixed n, which provides an indication 
of how much method accuracy is lost in the reliance on an a 
priori exponent. Overall, this analysis was conducted over 11 
individuals across two protocols, encompassing a total of 
166,659 heartbeats of data. 
3. RESULTS 
Table 1 provides an overview of the subject specific 
exponents, n, provided by linear least squares, along with the 
associated correlation coefficients and error values for 
tracking Ves. As can be seen, the correlation coefficients are 
high, with a mean of 0.83. Further, overall error values are 
relatively low, except for Pig D4 and the 75th percentile error 
for Pig D5. It is also interesting to note the generally higher 
error values for protocol 2 (dobutamine, Pig D-) compared to 
protocol 1 (sepsis, Pig S-). It was decided, for simplicity, to set 
the a priori value of n to 3 based on these results. 
Table 1. Tracking Ves with Subject Specific n: Correlation 








Pig S1 3.06 0.93 1.7 (0.9 - 3) 
Pig S2 4.02 0.94 2.9 (1.5 - 4.8) 
Pig S3 2.06 0.87 4.6 (2.2 - 7.2) 
Pig S4 2.72 0.8 4.7 (2.1 - 8.2) 
Pig S5 4.27 0.81 2.3 (0.9 - 7.7) 
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Table 2 provides an overview of the correlation coefficients 
and error values associated with tracking Ves using an a priori 
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exponent n = 3, as would be done clinically. Overall, there is 
only a slight increase in error, from 10.3% to 13.3% (mean of 
medians), and slight decrease in correlation coefficients, from 
R = 0.83 to R = 0.82 (mean). There is only once case (Pig D6) 
in which there is a large increase in error between Tables 1 and 
2. The notable difference in error values between the sepsis 
and dobutamine protocol pigs is also present in Table 2. 
Table 2. Tracking Ves with a priori n = 3: Correlation 
Coefficients and Errors, median (25th perc. – 75th perc.) 
Pig Correlation (R) 
Abs. Percentage 
Error, (%) 
Pig S1 0.94 1.8 (1.0 - 3.2) 
Pig S2 0.91 6.4 (4.6.0 - 9.8) 
Pig S3 0.84 4.5 (2.7.0 - 7.4) 
Pig S4 0.79 4.7 (2.1.0 - 8.1) 
Pig S5 0.8 4.2 (2.2.0 - 7.8) 
Pig D1 0.81 14.8 (3.6.0 - 28.5) 
Pig D2 0.84 15.2 (9.6.0 - 23.3) 
Pig D3 0.86 19.3 (9.5.0 - 35.6) 
Pig D4 0.71 33.7 (17.1.0 - 48.9) 
Pig D5 0.92 18.4 (7.5.0 - 85.3) 
Pig D6 0.66 23.3 (12.2.0 - 28.2) 
Mean 0.82 13.3 (6.6.0 - 26) 
 
 
Fig. 1. End-Systolic Volume trends and tracking for protocol 
1 (sepsis) 
Figures 1 and 2 visualise the approximation of Ves for each 
subject across both protocols. It is clear, there is a diverse 
range of subject specific responses to the various elements of 
each protocol, which are generally effectively tracked by the 
method with only a minor decrease in performance when 
shifting from a subject specific to an a priori exponent value. 
The sharp, vertical, and long term changes in Ves exclusive to 
Figure 2 demonstrate the effect of dobutamine in rapidly 
altering cardiac behaviour. In contrast, Ves in Figure 1 tends to 
change more gradually as sepsis develops over the course of 
the experiment. These latter results indicate the method 
accurately captures expected, induced changes in Ves, and does 
so in a subject specific fashion, capturing subject specific 
response to condition and care. 
 
Fig. 2. End-Systolic Volume trends and tracking for protocol 
2 (dobutamine) 
4. DISCUSSION 
As seen in Table 2, the correlation coefficients across all 11 
pigs and 2 protocols are reliably good, with a mean of 0.82 and 
minimum of 0.66. This result suggests that the method is able 
to effectively capture trends in Ves. The ability to track trends 
in Ves allows, in concert with SV, for tracking of preload which 
is important for patient diagnostics and monitoring purposes. 
That these high correlation coefficients are sustained across 11 
subjects and 2 protocols encompassing elements such as sepsis 
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and dobutamine, which dramatically alter cardiac function, 
provides a good initial validation of the method.  
While the ability to track trends is important for monitoring 
changes in patient condition, the ability to approximate the 
actual value of Ves is important for the method to be used as a 
component of larger models, and in providing a more complete 
picture of cardiac volume behaviour in the ICU. Table 2 show 
that the method is able to continuously estimate the value of 
Ves relatively effectively, with a mean median error of 13.3%, 
and mean 75th percentile error of 26.0%. Again, this accuracy 
is sustained over a number of subjects and a pair of different 
and demanding clinical protocols, suggesting the method is 
able to adapt to both short and long term changes in patient 
condition due to disease or drug therapy. 
Despite the considerable variation in the subject specific 
values of n, which range from 0.98 (Pig D6) to 4.27 (Pig S5), 
the use the a priori n = 3 results in only a relatively minor 
increase in error and decrease in correlation coefficients. A 
comparison between Tables 1 and 2 shows the largest decrease 
in correlation coefficient is a relatively minor reduction from 
R = 0.87 to R = 0.81. A similar comparison of error values 
shows minor increases in error between Table 1 and 2 in most 
cases, with the only major increase occurring for Pig D6. Pig 
D6 had the lowest subject specific exponent (n = 0.98), and 
Figure 2 shows n = 3 causes an overestimation of the decrease 
in Ves that results from a dobutamine infusion (at about 
heartbeat 7000). However, the method still predicts the 
direction of change correctly, and given the ability of the 
method to capture dobumatine shifts accurately for the other 5 
pigs in Figure 2, this case seems to be an exception, rather than 
the rule. 
There is a distinct increase in error values, though not a 
concordant decrease in R values, from Protocol 1 (sepsis) to 
the Protocol 2 (dobutamine). While the overall error values for 
both data sets are within acceptable levels, this shift does imply 
some level of condition dependency on the part of the method. 
One possibility is that dobutamine, which causes an artificial 
and externally administered alteration of cardiovascular 
behaviour, results in a shift in the sympathetic relationship 
between HR and Ees. While the method is still able to capture 
trends accurately, the exact magnitude of the patient response 
to dobutamine is difficult to predict, as in Pig D6, resulting in 
the observed increased error. This outcome would suggest the 
ability of the method to estimate the value of Ves would benefit 
from recalibration after the administration of drugs such as 
dobutamine, though the method performs well enough, 
regardless. 
There are a couple of limitations to this study that should be 
noted. First, the proposed method does require an 
echocardiography calibration to provide subject specific initial 
parameters. While echocardiography is non-invasive, and 
becoming increasingly commonplace in the ICU (Vieillard-
Baron et al., 2008), the method still cannot be implemented 
entirely without an increase in the workload of clinicians. 
Second, the method was validated across a limited data set. 
While effort was made to ensure the experimental protocols 
encompassed a variety of procedures, conditions and drugs 
with a variety of effects, this still represents only a fraction of 
the range of cardiac behaviour possible in an ICU. As such, 
further validation over more diverse data sets and subjects is 
needed.  
Specifically, there are several interventions that specifically 
alter either HR or contractility. Examples include inotropes, 
which increase contractility and were part of the validation, 
and vagus nerve stimulation (De Ferrari et al., 2011), which 
decreases HR. The method’s ability to adapt to inotropes, 
albeit with some increase in error, suggests that the method is 
capable of tracking changes through such interventions. 
Further, given that such interventions are instigated by a 
clinician, it would be relatively easy to recalibrate the method 
directly after an intervention should the method be shown to 
require it. 
5.  CONCLUSION 
Management of CVD in the ICU would benefit from better 
extraction of relevant cardiac metrics from the wealth of data 
regularly available in such an environment. A method was 
developed to allow clinical approximation of Ves beat-to-beat, 
using a modified ESPVR, brief echocardiography calibration 
and continuous Pao and HR data. This method was validated 
across 11 pigs and 2 protocols, covering sepsis, dobutamine 
infusion, recruitment manoeuvres and fluid infusions. The 
method was found to be able to track trends in Ves effectively 
across both protocols, with a mean correlation coefficient of R 
= 0.82. The method was also able to approximate the exact 
value of Ves effectively, with a mean-median absolute 
percentage error of 13.3%, though these errors were 
consistently higher for the protocol involving dobutamine than 
sepsis. Overall, this method, combined with an existing 
method that provides SV, allows for a more complete picture 
of cardiac volume behaviour to be established in the ICU, 
including metrics such as preload. This has the potential to 
benefit clinical management and decision making around 
CVD in the ICU. 
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picture of cardiac volume behaviour in the ICU. Table 2 show 
that the method is able to continuously estimate the value of 
Ves relatively effectively, with a mean median error of 13.3%, 
and mean 75th percentile error of 26.0%. Again, this accuracy 
is sustained over a number of subjects and a pair of different 
and demanding clinical protocols, suggesting the method is 
able to adapt to both short and long term changes in patient 
condition due to disease or drug therapy. 
Despite the considerable variation in the subject specific 
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the use the a priori n = 3 results in only a relatively minor 
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in correlation coefficient is a relatively minor reduction from 
R = 0.87 to R = 0.81. A similar comparison of error values 
shows minor increases in error between Table 1 and 2 in most 
cases, with the only major increase occurring for Pig D6. Pig 
D6 had the lowest subject specific exponent (n = 0.98), and 
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in Ves that results from a dobutamine infusion (at about 
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pigs in Figure 2, this case seems to be an exception, rather than 
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There is a distinct increase in error values, though not a 
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some level of condition dependency on the part of the method. 
One possibility is that dobutamine, which causes an artificial 
and externally administered alteration of cardiovascular 
behaviour, results in a shift in the sympathetic relationship 
between HR and Ees. While the method is still able to capture 
trends accurately, the exact magnitude of the patient response 
to dobutamine is difficult to predict, as in Pig D6, resulting in 
the observed increased error. This outcome would suggest the 
ability of the method to estimate the value of Ves would benefit 
from recalibration after the administration of drugs such as 
dobutamine, though the method performs well enough, 
regardless. 
There are a couple of limitations to this study that should be 
noted. First, the proposed method does require an 
echocardiography calibration to provide subject specific initial 
parameters. While echocardiography is non-invasive, and 
becoming increasingly commonplace in the ICU (Vieillard-
Baron et al., 2008), the method still cannot be implemented 
entirely without an increase in the workload of clinicians. 
Second, the method was validated across a limited data set. 
While effort was made to ensure the experimental protocols 
encompassed a variety of procedures, conditions and drugs 
with a variety of effects, this still represents only a fraction of 
the range of cardiac behaviour possible in an ICU. As such, 
further validation over more diverse data sets and subjects is 
needed.  
Specifically, there are several interventions that specifically 
alter either HR or contractility. Examples include inotropes, 
which increase contractility and were part of the validation, 
and vagus nerve stimulation (De Ferrari et al., 2011), which 
decreases HR. The method’s ability to adapt to inotropes, 
albeit with some increase in error, suggests that the method is 
capable of tracking changes through such interventions. 
Further, given that such interventions are instigated by a 
clinician, it would be relatively easy to recalibrate the method 
directly after an intervention should the method be shown to 
require it. 
5.  CONCLUSION 
Management of CVD in the ICU would benefit from better 
extraction of relevant cardiac metrics from the wealth of data 
regularly available in such an environment. A method was 
developed to allow clinical approximation of Ves beat-to-beat, 
using a modified ESPVR, brief echocardiography calibration 
and continuous Pao and HR data. This method was validated 
across 11 pigs and 2 protocols, covering sepsis, dobutamine 
infusion, recruitment manoeuvres and fluid infusions. The 
method was found to be able to track trends in Ves effectively 
across both protocols, with a mean correlation coefficient of R 
= 0.82. The method was also able to approximate the exact 
value of Ves effectively, with a mean-median absolute 
percentage error of 13.3%, though these errors were 
consistently higher for the protocol involving dobutamine than 
sepsis. Overall, this method, combined with an existing 
method that provides SV, allows for a more complete picture 
of cardiac volume behaviour to be established in the ICU, 
including metrics such as preload. This has the potential to 
benefit clinical management and decision making around 
CVD in the ICU. 
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